TGF-beta/OPTN/FOXC1/miR-200 axis regulates intraocular pressure dynamics in trabecular meshwork cells

Aramati Bindu Madhava Reddy,Chennakesavulu Sugali,Navya Naidu Gajula,Suresh Chava
DOI: https://doi.org/10.1101/2024.06.06.593675
2024-06-06
Abstract:Glaucoma is the second leading cause of irreversible blindness globally, with elevated intraocular pressure (IOP) being its primary risk factor. Current therapeutic approaches, such as beta-blockers, alpha-adrenergic agonists, Rho-kinase inhibitors, etc., aim to reduce IOP levels. However, the molecular mechanisms underlying altered IOP remain poorly understood. In this study, we have treated primary human trabecular meshwork cells (HTM) with exogenous dexamethasone (dex) or transforming growth factor beta-2 (TGF-beta2) to investigate its effects on glaucoma candidate genes. Interestingly, our findings reveal that FOXC1 acts as a repressor to CYP1B1, and optineurin (OPTN) facilitates the ubiquitination of FOXC1, thereby inducing CYP1B1 expression. Further, we discovered that the miR-200 family and other miRNAs regulate these glaucoma-candidate genes. Furthermore, TGF-beta2 downregulates the miR-200 family, whereas the miR-200 family targets FOXC1, exerting reversible effects by altering the extracellular matrix. FOXC1 positively regulates CLOCK, one of its target genes. Besides, CLOCK/BMAL1 has binding sites on miR-200 family promoters. Modulating the TGF-beta2/OPTN/FOXC1/miR-200 axis appears critical in regulating IOP dynamics through CLOCK/BMAL1-mediated daily rhythmicity in the anterior segment of the eye.
Cell Biology
What problem does this paper attempt to address?